Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Insights and Strategies of Melanoma Immunotherapy: Predictive Biomarkers of Response and Resistance and Strategies to Improve Response Rates
Attila A. Seyhan, Claudio Carini
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 41-41
Open Access | Times Cited: 10

Showing 10 citing articles:

Rheumatic Immune-Related Adverse Events due to Immune Checkpoint Inhibitors—A 2023 Update
Quang Minh Dang, Ryu Watanabe, Mayu Shiomi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5643-5643
Open Access | Times Cited: 21
Navigating the Immune Maze: Pioneering Strategies for Unshackling Cancer Immunotherapy Resistance
Liqin Yao, Qingqing Wang, Wenxue Ma
Cancers (2023) Vol. 15, Iss. 24, pp. 5857-5857
Open Access | Times Cited: 14
Circulating cytokine dynamics as potential biomarker of response to anti-PD-1 immunotherapy in BRAFwt MM patients
Katarina Mirjačić Martinović, Ana Vuletić, Nevena Tišma Miletić, et al.
Translational Oncology (2023) Vol. 38, pp. 101799-101799
Open Access | Times Cited: 13
Age-Related Variations in Clinical, Histological, and Genetic Characteristics in Multiple and Familial Melanomas: A Study of 333 Patients
Andrea Carugno, Giovanni Paolino, Mario Valenti, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 3, pp. 686-686
Open Access
Identification of tumor immune infiltration-associated VPS72 and prognostic significance of VPS72 and CD8A in hepatocellular carcinoma
Yang Zhou, Xiao Feng, Haoyuan Yu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Advancing Cancer Treatment: A Review of Immune Checkpoint Inhibitors and Combination Strategies
Valencia Mc Neil, Seung Won Lee
Cancers (2025) Vol. 17, Iss. 9, pp. 1408-1408
Open Access
Exploring the clinical significance of specific immune-related adverse events in melanoma patients undergoing immune checkpoint inhibitor therapy
Nethanel Asher, Neta Bar-Hai, Guy Ben‐Betzalel, et al.
Melanoma Research (2024)
Open Access | Times Cited: 2
PD-1/PD-L1 Inhibitors Response in Triple-Negative Breast Cancer: Can Long Noncoding RNAs Be Associated?
Carolina Mathias, Vanessa Nascimento Kozak, Jessica Maria Magno, et al.
Cancers (2023) Vol. 15, Iss. 19, pp. 4682-4682
Open Access | Times Cited: 4
CSDE1 Intracellular Distribution as a Biomarker of Melanoma Prognosis
Alberto Indacochea, Tanit Guitart, Aram Boada, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2319-2319
Open Access
Exploring the Clinical Significance of Specific Immune-Related Adverse Events (irAE) in Melanoma Patients Undergoing Immune Checkpoint Inhibitor (ICI) Therapy
Nathanel Asher, Neta Bar-Hai, Guy Ben‐Betzalel, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top